Charles River Laboratories Earnings

The next earnings date for Charles River Laboratories is May 7, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Charles River Laboratories Earnings

Report DateEstimated Earnings Per Share
05/07/2026$1.93

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Charles River Laboratories Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
02/18/2026---$0-100.00%
11/05/2025Before Market$0-100.00%
08/06/2025---$3.1224.80%
05/07/2025Before Market$2.3412.78%
02/12/2025Before Market$2.665.24%
11/06/2024Before Market$2.596.58%
08/07/2024Before Market$2.8017.15%
05/09/2024Before Market$2.279.66%
02/14/2024Before Market$2.462.50%
11/08/2023Before Market$2.7214.77%
08/09/2023Before Market$2.691.89%
05/11/2023Before Market$2.787.34%
02/22/2023Before Market$2.988.36%
11/02/2022Before Market$2.635.20%
08/03/2022Before Market$2.771.47%
05/04/2022Before Market$2.751.10%
02/16/2022Before Market$2.492.47%
11/03/2021Before Market$2.704.65%
08/04/2021Before Market$2.619.66%
05/04/2021Before Market$2.5315.53%
02/17/2021Before Market$2.3913.27%
10/29/2020Before Market$2.3329.44%
08/05/2020Before Market$1.5825.40%
05/07/2020Before Market$1.8424.32%
02/11/2020Before Market$2.019.84%
11/06/2019Before Market$1.693.68%
07/31/2019Before Market$1.635.16%
05/07/2019Before Market$1.401.45%
02/13/2019Before Market$1.496.43%
11/07/2018Before Market$1.5310.87%
08/08/2018Before Market$1.6210.96%
05/10/2018Before Market$1.389.52%
02/13/2018Before Market$1.4012.00%
11/09/2017Before Market$1.306.56%
08/09/2017Before Market$1.295.74%
05/10/2017Before Market$1.2913.16%
02/14/2017Before Market$1.219.01%
11/02/2016Before Market$1.184.42%
08/03/2016Before Market$1.209.09%
05/04/2016Before Market$0.988.89%
02/10/2016Before Market$16.38%
11/04/2015Before Market$1.039.57%
07/30/2015Before Market$0.96-1.03%
04/29/2015After Market$0.79-3.66%
02/10/2015After Market$0.8114.08%
10/29/2014After Market$0.867.50%
08/06/2014---$0.9718.29%
04/30/2014---$0.8210.81%
02/11/2014---$0.737.35%
10/29/2013---$0.7912.86%
07/31/2013---$0.732.82%
05/01/2013---$0.69-2.82%
02/13/2013---$0.646.67%
10/30/2012---$0.654.84%
08/07/2012---$0.7513.64%
05/02/2012---$0.707.69%
02/13/2012---$0.6923.21%
11/01/2011---$0.57-1.72%
08/02/2011---$0.7016.67%
05/03/2011---$0.6110.91%
02/08/2011---$0.6022.45%
11/03/2010---$0.45-8.16%
08/02/2010---$0.49-2.00%
04/26/2010---$0.45-4.26%
02/08/2010---$0.4911.36%
11/03/2009---$0.658.33%
08/04/2009---$0.6613.79%
05/05/2009---$0.589.43%
02/09/2009---$0.597.27%
11/05/2008---$0.761.33%
08/05/2008---$0.798.22%
05/06/2008---$0.724.35%
02/11/2008---$0.653.17%
11/05/2007---$0.6911.29%
08/07/2007---$0.643.23%
05/08/2007---$0.644.92%
02/12/2007---$0.580.00%
11/06/2006---$0.563.70%
08/08/2006---$0.577.55%
05/09/2006---$0.50-12.28%
02/08/2006---$0.593.51%
10/27/2005---$0.570.00%
07/28/2005---$0.59-1.67%
05/03/2005---$0.550.00%
02/14/2005---$0.482.13%
10/28/2004---$0.514.08%
07/28/2004---$0.526.12%
04/28/2004---$0.476.82%
02/10/2004---$0.4210.53%
10/29/2003---$0.400.00%
07/29/2003---$0.422.44%
04/30/2003---$0.412.50%
02/03/2003---$0.360.00%
10/29/2002---$0.398.33%
07/30/2002---$0.3612.50%
05/01/2002---$0.3114.81%
02/06/2002---$0.240.00%
10/31/2001---$0.2613.04%
08/02/2001---$0.2414.29%
05/04/2001---$0.1911.76%
02/14/2001---$0.1122.22%
11/01/2000---$0.1250.00%
08/02/2000---$0.18125.00%

More About Charles River Laboratories

Country
USA
Full Time Employees
18,300

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, it has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Charles River Laboratories Earnings” Can Refer to the Charles River Laboratories Earnings Date

Some people say “Charles River Laboratories earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Charles River Laboratories position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Charles River Laboratories Stock on the Earnings Date

If you own Charles River Laboratories stock (CRL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Charles River Laboratories might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Charles River Laboratories shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Charles River Laboratories Earnings

You can contact us any time if you would like to ask questions about Charles River Laboratories earnings or anything else related to the stock market.